KineRuby

Research

HomeCL overviewFinancial chartsStock screener

Valuation & planning

DCF valuationCompound interestDividend snowballAll tools

Watchlist

Star a ticker to pin it here.

KineRubyLog in
HomeAnalysisScreenerTools
Colgate-Palmolive Company logo

Colgate-Palmolive Company

CLNYSE

$97.20

Last price · USD

Market cap
$78.84B
P/E
37.0x
EV / EBITDA
17.7x
P/S
3.9x
FCF yield
4.6%
Div. yield
2.31%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

OverviewBusinessFinancialsPeersChartsValuation

Revenue

$20.38B

+1.4%

4Y CAGR +4.0%

Gross profit

$12.25B

+1.2%

4Y CAGR +4.4%

Operating income

$3.31B

-24.6%

4Y CAGR -4.0%

Net income

$2.13B

-26.2%

4Y CAGR -0.4%

EPS (diluted)

$2.63

-25.1%

4Y CAGR +0.8%

Free cash flow

$3.63B

+2.5%

4Y CAGR +7.1%

Revenue & net income

Fiscal 2021–2025 · USD

All charts
$20B$16B$12B$8B$4B$0M$17.42B$17.97B$19.46B$20.10B$20.38B20212022202320242025
RevenueNet income

Valuation

At $97.20 · FY2025 fundamentals

Market cap
$78.84B
Enterprise value
$86.10B
P/E
37.0x
P/S
3.9x
P/B
1460.0x
EV / EBITDA
17.7x
EV / Sales
4.2x
Earnings yield
2.7%
FCF yield
4.6%
Shareholder yield
3.8%
Estimate intrinsic value with a DCF

Profitability

Margins as a share of revenue

MetricLatest4Y agoTrend
Gross margin60.1%+1.0pp59.1%
Operating margin16.2%-6.1pp22.3%
EBITDA margin23.9%+2.3pp21.6%
Net margin10.5%-2.0pp12.4%
FCF margin17.8%+2.0pp15.8%

Returns & financial health

FY2025 with 4-year trend

MetricLatest4Y agoTrend
Return on equity3948.1%355.7%
Return on invested capital33.4%38.7%
Return on assets13.1%14.4%
Debt / equity158.41x12.86x
Net debt / EBITDA1.49x1.86x
Current ratio0.83x1.09x

Cash & equivalents

$1.29B

Total debt

$8.55B

Capital allocation

How CL used its cash in FY2025

Operating cash flow
$4.20B
Capital expenditure
$564M
Dividends paid
$1.82B
Share repurchases
$1.21B
Stock-based compensation
$0.00
Diluted shares
811.1M
Share count change (4Y)
-4.4%

Analyst estimates

Consensus for upcoming fiscal years

Fiscal yearRevenueGrowthEPSGrowth
FY2025 actual$20.38B$2.63
FY2026E11 analysts$21.42B+5.1%$3.86+46.7%
FY2027E12 analysts$22.09B+3.1%$4.08+5.8%
FY2028E6 analysts$22.89B+3.7%$4.39+7.4%

About Colgate-Palmolive Company

Consumer Defensive · Household & Personal Products

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.

colgatepalmolive.com
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Noel R. Wallace
Employees
33,600
Headquarters
New York City, NY, US
IPO date
1973-05-02

Colgate-Palmolive Company (CL) — frequently asked questions

Answered from the company's SEC filings

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition.

Colgate-Palmolive Company reported revenue of $20.38B in fiscal 2025, up 1.4% from the prior year. Over the last 4 years, revenue has grown at 4.0% a year.

Yes. Colgate-Palmolive Company earned net income of $2.13B in fiscal 2025, a net margin of 10.5%, and generated $3.63B of free cash flow.

At a share price of $97.20, CL trades at about 37.0x its fiscal 2025 earnings per share, with a market capitalization of roughly $78.84B. Its EV/EBITDA multiple is 17.7x.

Yes. Colgate-Palmolive Company paid $1.82B in dividends to shareholders in fiscal 2025, a dividend yield of about 2.31% at today's price.

Colgate-Palmolive Company had total debt of $8.55B and cash of $1.29B at the end of fiscal 2025, giving net debt of 1.5x EBITDA.

Colgate-Palmolive Company's return on invested capital was 33.4% in fiscal 2025, and its return on equity was 3948.1%.

Explore the full income statement, balance sheet and cash flow statement. Not investment advice.